Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Kammertöns, Thomas Dr. (3) Kettenmann, Helmut Prof. Dr. (1) Leisegang, Matthias Dr. (4) Obenaus, Matthias (1) Poncette, Lucia (1) Rhein, Simone Dr. (1) Stein, Ulrike Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (15) Walther, Wolfgang Prof. Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (8) (-) Gavvovidis, Ioannis Dr. (1) (-) Lorenz, Felix Dr. (3) Bioinformatics (1) Biologie maligner Lymphome (15) Entwicklungsneurobiologie (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Molekulare Immunologie und Gentherapie (28) Molekulare Immuntherapie (6) (-) Molekulare Zellbiologie und Gentherapie (10) Proteom Dynamik (1) Signaltransduktion in Tumorzellen (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) (-) 1998 (2) 2000 (2) 2003 (4) 2004 (1) 2005 (3) 2006 (2) (-) 2007 (1) 2008 (1) 2010 (1) (-) 2011 (2) 2014 (1) (-) 2015 (3) 2016 (2) 2017 (2) (-) 2019 (2) 10 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Gavvovidis, Ioannis Dr.Lorenz, Felix Dr.Molekulare Zellbiologie und Gentherapie19982007201120152019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 02. Januar 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein 01. Januar 2019 in Cancer Immunol Res Mapping the MHC class I spliced immunopeptidome of cancer cells J. Liepe J. Sidney F.K.M. Lorenz A. Sette M. Mishto 01. April 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 23. März 2015 in PLoS ONE Codon optimization of the human papillomavirus E7 oncogene induces a CD8(+) T cell response to a cryptic epitope not harbored by wild-type E7 F.K.M. Lorenz S. Wilde K. Voigt E. Kieback B. Mosetter D.J. Schendel W. Uckert 28. Juli 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 15. Januar 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 15. Oktober 2007 in J Immunol Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity M. Weinhold D. Sommermeyer W. Uckert T. Blankenstein 01. Januar 1998 in Hum Gene Ther Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo W. Uckert T. Kammertoens K. Haack Z. Qin J. Gebert D.J. Schendel T. Blankenstein 01. Januar 1998 in Hum Gene Ther RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes W. Uckert G. Willimsky F.S. Pedersen T. Blankenstein L. Pedersen
02. Januar 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein
01. Januar 2019 in Cancer Immunol Res Mapping the MHC class I spliced immunopeptidome of cancer cells J. Liepe J. Sidney F.K.M. Lorenz A. Sette M. Mishto
01. April 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
23. März 2015 in PLoS ONE Codon optimization of the human papillomavirus E7 oncogene induces a CD8(+) T cell response to a cryptic epitope not harbored by wild-type E7 F.K.M. Lorenz S. Wilde K. Voigt E. Kieback B. Mosetter D.J. Schendel W. Uckert
28. Juli 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
15. Januar 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
15. Oktober 2007 in J Immunol Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity M. Weinhold D. Sommermeyer W. Uckert T. Blankenstein
01. Januar 1998 in Hum Gene Ther Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo W. Uckert T. Kammertoens K. Haack Z. Qin J. Gebert D.J. Schendel T. Blankenstein
01. Januar 1998 in Hum Gene Ther RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes W. Uckert G. Willimsky F.S. Pedersen T. Blankenstein L. Pedersen
